SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056171
Filing Date
2021-11-10
Accepted
2021-11-10 16:04:44
Documents
67
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20210930.htm   iXBRL 10-Q 2671279
2 EX-31.1 scyx-ex311_10.htm EX-31.1 18623
3 EX-31.2 scyx-ex312_6.htm EX-31.2 19262
4 EX-32.1 scyx-ex321_9.htm EX-32.1 9419
  Complete submission text file 0001564590-21-056171.txt   11842829

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA scyx-20210930.xsd EX-101.SCH 60946
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20210930_cal.xml EX-101.CAL 59971
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20210930_def.xml EX-101.DEF 215791
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20210930_lab.xml EX-101.LAB 511317
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20210930_pre.xml EX-101.PRE 385992
10 EXTRACTED XBRL INSTANCE DOCUMENT scyx-10q_20210930_htm.xml XML 2979620
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 211396477
SIC: 2834 Pharmaceutical Preparations